? The overall goal of this research is to create and apply a unique dual-modality system for time-series imaging of colon cancer development in mice. Miniaturized optical coherence tomography (OCT), laser induced fluorescence (LIF), and novel contrast agents are combined into a sensitive structural and biochemical imaging system. The minimally invasive nature of this system means that the development (and response to treatment) of each individual tumor can be tracked in vivo. This study is divided into 4 specific aims: 1. Design, build and test miniature combined OCTILIF catheters. We propose to build a high-throughput probe with ability to measure the entire lower colon with one insertion. Subsequently, we propose to build a large bandwidth catheter that supports very high resolution imaging. 2. Develop novel contrast agents for improved visualization of tumors. Contrast agents may help identify the earliest stages of carcinogenesis. We will investigate three classes: a) gold-coated nanoshells, which we have shown to have an extremely bright OCT signature, b) liposomes, which incorporate fluorescent dyes, and c) dietary cholorphyll, These agents will be tested in phantoms, cell cultures, and mouse models. 3. Perform studies of DMH-treated and MIN mice with and without contrast agents and NSAID administration. Two mouse models, DMH-treated and genetically altered multiple intestinal neoplasia (MIN) will be utilized in this specific aim. In a series of studies, the lower colon of these mice will be imaged every 3-6 weeks to evaluate tumorigenesis. The effect of non-steroidal anti-inflammatory agent (NSAID) preventive and therapeutic treatment will be assessed, as will enhancement of image contrast with the contrast agents in specific aim 2. 4. Develop analysis tools for interpreting OCT images and LIF spectra. Storage and retrieval software will be developed. For analyzing OCT images, texture analysis and automated layer thickness measurements will be used, and for LIF spectra, component analysis and intrinsic fluorescence extraction methods will be employed. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109385-02
Application #
6905572
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Baker, Houston
Project Start
2004-07-01
Project End
2009-04-30
Budget Start
2005-07-01
Budget End
2006-04-30
Support Year
2
Fiscal Year
2005
Total Cost
$309,608
Indirect Cost
Name
University of Arizona
Department
Type
Organized Research Units
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Welge, Weston A; Barton, Jennifer K (2017) In vivo endoscopic Doppler optical coherence tomography imaging of the colon. Lasers Surg Med 49:249-257
Chandra, Swati; Nymeyer, Ariel C; Rice, Photini Faith et al. (2017) Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model. Cancer Prev Res (Phila) 10:459-466
Harpel, Kaitlin; Leung, Sarah; Rice, Photini Faith et al. (2016) Imaging colon cancer development in mice: IL-6 deficiency prevents adenoma in azoxymethane-treated Smad3 knockouts. Phys Med Biol 61:N60-9
LeGendre-McGhee, Susan; Rice, Photini S; Wall, R Andrew et al. (2015) Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography. Cancer Growth Metastasis 8:63-80
Leung, Sarah J; Rice, Photini S; Barton, Jennifer K (2015) In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis. Lasers Surg Med 47:40-9
Keenan, Molly R; Leung, Sarah J; Rice, Photini S et al. (2015) Dual optical modality endoscopic imaging of cancer development in the mouse colon. Lasers Surg Med 47:30-9
Welge, Weston A; Barton, Jennifer K (2015) Expanding Functionality of Commercial Optical Coherence Tomography Systems by Integrating a Custom Endoscope. PLoS One 10:e0139396
Carbary-Ganz, Jordan L; Barton, Jennifer K; Utzinger, Urs (2014) Quantum dots targeted to vascular endothelial growth factor receptor 2 as a contrast agent for the detection of colorectal cancer. J Biomed Opt 19:086003
Wall, R Andrew; Barton, Jennifer K (2014) Oblique incidence reflectometry: optical models and measurements using a side-viewing gradient index lens-based endoscopic imaging system. J Biomed Opt 19:067002
Gainer, Christian F; Romanowski, Marek (2013) Multiphoton Imaging of Upconverting Lanthanide Nanoparticles in Three Dimensional Models of Cancer. Proc SPIE Int Soc Opt Eng 8595:

Showing the most recent 10 out of 26 publications